BioCentury | Jun 9, 2017
Financial News

Lung Therapeutics raises $14.3M in series B

...Texas) raised $14.3 million in a series B round led by Bios Partners. Founding investor UT Horizon Fund...
BioCentury | Jun 7, 2017
Company News

Lung Therapeutics raises $14.3M series B round

...Texas) raised $14.3 million in a series B round led by Bios Partners. Founding investor UT Horizon Fund...
BioCentury | Mar 30, 2015
Financial News

Aeglea completes venture financing

...Date completed: 2015-03-23 Type: Venture financing Raised: $44 million Investors: Lilly Ventures; Novartis Venture Funds; UT Horizon Fund...
BioCentury | Mar 30, 2015
Emerging Company Profile

Effusion dissolution

...Pulmonary Clinical status: Preclinical Founded: 2013 by University of Texas Health Science Center at Tyler, UT Horizon Fund...
...None Number of employees: 1 Funds raised: $1.8 million Investors: SCM-Bios Lung Therapeutics SPV LP, UT Horizon Fund...
BioCentury | Mar 30, 2015
Finance

Aeglea's crossover

...million round was led by existing investors Lilly Ventures and Novartis Venture Fund. Existing investor UT Horizon Fund...
BioCentury | Mar 24, 2015
Financial News

Aeglea raises $44M in series B

...series B round led by existing investors Lilly Ventures and Novartis Venture Fund. Existing investor UT Horizon Fund...
BioCentury | Sep 22, 2014
Finance

Academic ventures

...Regents, which manages UC's retirement, endowment and cash assets. UC Ventures will be similar to UT Horizon Fund...
Items per page:
1 - 7 of 7
BioCentury | Jun 9, 2017
Financial News

Lung Therapeutics raises $14.3M in series B

...Texas) raised $14.3 million in a series B round led by Bios Partners. Founding investor UT Horizon Fund...
BioCentury | Jun 7, 2017
Company News

Lung Therapeutics raises $14.3M series B round

...Texas) raised $14.3 million in a series B round led by Bios Partners. Founding investor UT Horizon Fund...
BioCentury | Mar 30, 2015
Financial News

Aeglea completes venture financing

...Date completed: 2015-03-23 Type: Venture financing Raised: $44 million Investors: Lilly Ventures; Novartis Venture Funds; UT Horizon Fund...
BioCentury | Mar 30, 2015
Emerging Company Profile

Effusion dissolution

...Pulmonary Clinical status: Preclinical Founded: 2013 by University of Texas Health Science Center at Tyler, UT Horizon Fund...
...None Number of employees: 1 Funds raised: $1.8 million Investors: SCM-Bios Lung Therapeutics SPV LP, UT Horizon Fund...
BioCentury | Mar 30, 2015
Finance

Aeglea's crossover

...million round was led by existing investors Lilly Ventures and Novartis Venture Fund. Existing investor UT Horizon Fund...
BioCentury | Mar 24, 2015
Financial News

Aeglea raises $44M in series B

...series B round led by existing investors Lilly Ventures and Novartis Venture Fund. Existing investor UT Horizon Fund...
BioCentury | Sep 22, 2014
Finance

Academic ventures

...Regents, which manages UC's retirement, endowment and cash assets. UC Ventures will be similar to UT Horizon Fund...
Items per page:
1 - 7 of 7